QA: Neos Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467652_2016_Neos_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001467652, Neos Therapeutics Inc

  xvar xval
0 AssetsCurrent 98,244,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,124,000
3 remainder_Assets 19,142,000
4 LiabilitiesCurrent 15,938,000
5 LiabilitiesNoncurrent 28,198,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 5,547,000
8 SellingGeneralAndAdministrativeExpense 7,474,000
9 ResearchAndDevelopmentExpense 11,887,000
10 remainder_Expenses 6,775,000
11 remainder_Revenues 3,792,000
12 remainder_NetIncome -2,890,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 122,510,000
1 Liabilities 44,136,000
2 Expenses 31,683,000
3 Revenues 3,792,000
4 StockholdersEquity 78,374,000
5 NetIncome -30,781,000
6 ComprehensiveNetIncome -30,781,000
7 BaseVar 102,505,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.68
9 EconomicCapitalRatio 2.81

Edgar->Model Mapping

Feature Distribution